Latest Information Update: 27 Sep 2006
At a glance
- Originator Sindan
- Class Antivirals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 27 Sep 2006 Discontinued - Preclinical for Viral infections in Romania (unspecified route)
- 29 Nov 2000 New profile
- 29 Nov 2000 Preclinical development for Viral infections in Romania (Unknown route)